PKCα has also been implicated in drug sensitivity and resistance acquisition and was reported to mediate doxorubicin sensitivity by phosphorylation of RLIP76 in NSCLC [40,41]. The gene discussed is PRKCA; the disease is non-small cell lung carcinoma.